Comparison results
| Results: Differences General | ✘Chronic monocytic leukemia | ✘D62 | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
| chronic monocytic leukemia | 92% | — | ||||||||||
| acute blood loss | — | 95% | ||||||||||
| acute leukemia | 61% | — | ||||||||||
| bleeding | — | 69% | ||||||||||
| monocytosis | 58% | — | ||||||||||
| the volume of blood loss is reduced | — | 67% | ||||||||||
| professional cancer | 48% | — | ||||||||||
| latent iron deficiency | — | 64% | ||||||||||
| thrombocytopenia | 36% | — | ||||||||||
| iron deficiency anemia | — | 63% | ||||||||||
| waldenstrom 's macroglobulinemia | 34% | — | ||||||||||
| hypochromia | — | 63% | ||||||||||
| chronic leukemia | 33% | — | ||||||||||
| thrombocytopathy | — | 56% | ||||||||||
| chronic myeloid leukemia | 31% | — | ||||||||||
| anemia | 22% | 73% | ||||||||||
| increased gamma globulins | 29% | — | ||||||||||
| monthly abundant and prolonged | — | 51% | ||||||||||
| subacute condition | 26% | — | ||||||||||
| very abundant monthly | — | 51% | ||||||||||
| hepatosplenomegaly | 23% | — | ||||||||||
| hemorrhagic vasculitis | — | 51% | ||||||||||
| enlargement of the liver and spleen | 23% | — | ||||||||||
| aplastic anemia | — | 51% | ||||||||||
| metastases | 23% | — | ||||||||||
| pulmonary hemorrhage | — | 48% | ||||||||||
| more often in old age | 23% | — | ||||||||||
| diuresis is reduced | — | 48% | ||||||||||
| very correct | 22% | — | ||||||||||
| dizziness when getting | — | 45% | ||||||||||
| enlargement of the spleen | 22% | — | ||||||||||
| dic syndrome | — | 44% | ||||||||||
| increased ESR | 22% | — | ||||||||||
| palpitations with shortness of breath | — | 43% | ||||||||||
| enlarged liver | 20% | — | ||||||||||
| trauma | — | 43% | ||||||||||
| tuberculosis | 20% | — | ||||||||||
| coagulopathy | — | 43% | ||||||||||
| leukocytosis | 20% | — | ||||||||||
| menstruation disorder | — | 42% | ||||||||||
| high temperature | 18% | — | ||||||||||
| no strength | — | 40% | ||||||||||
| feeling of heat | 18% | — | ||||||||||
| lack of breath | — | 39% | ||||||||||
| childhood diseases | 17% | — | ||||||||||
| dehydration | — | 37% | ||||||||||
| lowered | 62% | 50% | ||||||||||
| hemorrhagic diathesis | — | 36% | ||||||||||
| dyspnea | — | 35% | ||||||||||
| palpitations | — | 34% | ||||||||||
| consequences of injuries | — | 34% | ||||||||||
| blood diseases | 33% | 64% | ||||||||||
| oncology | — | 30% | ||||||||||
| consequences of taking medications | — | 29% | ||||||||||
| erythrocytic anemia | 34% | 62% | ||||||||||
| hemorrhagic syndrome | 26% | 48% | ||||||||||
| chronic anemia | 22% | 40% | ||||||||||
| leukemia | 27% | 43% | ||||||||||
| cancer | 21% | 32% | ||||||||||
Instructions
Video
|